Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 11 citing articles:

STAT3 pathway in cancers: Past, present, and future
Hanqi Wang, Qi‐Wen Man, Fang‐Yi Huo, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 107
Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas
Jiwei Cui, Yuanxin Xu, Haiyan Tu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 3, pp. 1100-1125
Open Access | Times Cited: 32
STAT3 Signaling Pathway in Health and Disease
Md Abdus Samad, Iftikhar Ahmad, A. M. Mahedi Hasan, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
RUNX3 enhances TRAIL-induced apoptosis by upregulating DR5 in colorectal cancer
Bo Ram Kim, Seong Hye Park, Yoon A Jeong, et al.
Oncogene (2019) Vol. 38, Iss. 20, pp. 3903-3918
Closed Access | Times Cited: 33
Anticancer activity of NFκB decoy oligonucleotide-loaded nanoparticles against human lung cancer
Vinod K. Kannaujiya, Gabriele De Rubis, Keshav Raj Paudel, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 82, pp. 104328-104328
Closed Access | Times Cited: 8
Nanoparticle-Mediated Delivery of STAT3 Inhibitors in the Treatment of Lung Cancer
Qiyi Feng, Kai Xiao
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2787-2787
Open Access | Times Cited: 14
Recent Development of LDL-Based Nanoparticles for Cancer Therapy
Binghong He, Qiong Yang
Pharmaceuticals (2022) Vol. 16, Iss. 1, pp. 18-18
Open Access | Times Cited: 11
Design and encapsulation of anticancer dual HSP27 and HER2 inhibitor into low density lipoprotein to target ovarian cancer cells
Laila Jarragh Alhadad, Gamaleldin I. Harisa, Fars K. Alanazi
Saudi Pharmaceutical Journal (2020) Vol. 28, Iss. 4, pp. 387-396
Open Access | Times Cited: 14
Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition
Saleh A. Alanazi, Gamaleldin I. Harisa, Mohamed M. Badran, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 914-926
Open Access | Times Cited: 9
Effect of STAT3 decoy oligodeoxynucleotides mediated by ultrasound-targeted microbubbles combined with ultrasound on the growth of squamous cell carcinoma of the esophagus
Yan Zhang, Meiwu Zhang, Xiaoxiang Fan, et al.
Oncology Letters (2018)
Open Access | Times Cited: 6
Recent Progress of Nanomedicine and Targeted Drug Delivery for Cancer Treatment

MDPI eBooks (2023)
Open Access
Page 1

Scroll to top